A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

Cell

Volumn 92, Issue 4, 1998, Pages 451-462

  Wei, Ping ^a   Garber, Mitchell E ^a,b   Fang, Shi Min ^a   Fischer, Wolfgang H ^a   Jones, Katherine A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN C RELATED PROTEIN; CYCLINE; RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN ISOLATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0032548918     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80939-3     Document Type: Article

References (48)

1. Alonso, A., Cujec, T., and Peterlin, B. (1994). Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J. Virol. 66, 6505-6513.
2. Bellier, S., Chastant, S., Adenot, P., Vincent, M., Renard, J., and Bensaude, O. (1997). Nuclear translocation and carboxyl-terminal domain phosphorylation of RNA polymerase II delineate the two phases of zygotic gene activation in mammalian embryos. EMBO J. 16, 6250-6262.
3. Boelens, W., Scherly, D., Beijer, R., Jansen, E., Dathan, N., Mattaj, I., and van Venrooij, W. (1991). A weak interaction between the U2A′ protein and the U2 snRNA helps to stablilize their complex with the U2B″ protein. Nucleic Acids Res. 19, 455-460.
4. Churcher, M., Lament, C., Hamy, F., Dingwall, C., Green, S., Lowe, A., Butler, P., Gait, M., and Karn, J. (1993). High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 230, 90-110.
5. Cooper, K., Mallory, M., Smith, J., and Strich, R. (1997). Stress and developmental regulation of the yeast C-type cyclin UmeSp (Srb 11p/ Ssn8p). EMBO J. 16, 4665-4675.
6. Cujec, T., Cho, H., Maldonado, E., Meyer, J., Reinberg, D., and Peterlin, B. (1997). The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17, 1817-1823.
7. Cullen, B. (1993). Does HIV-1 Tat induce a change in viral initiation rights? Cell 73, 417-420.
8. Dubois, M., Nguyen, V., Dahmus, M., Pages, G., Pouyssegur, J., and Bensaude, O. (1994). Enhanced phosphorylation of the C-terminal domain of RNA polymerase II upon serum stimulation of quiescent cells: possible involvement of MAP kinases. EMBO J. 13, 4787-4797.
9. Fisher, R., and Morgan, D. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724.
10. Fisher, R., Jin, P., Chamberlin, H., and Morgan, D. (1995). Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83, 47-57.
11. Furnari, B., Russell, P., and Leatherwood, J. (1997). Pch1(+), a second essential C-type cyclin gene in Schizosaccharomyces pombe. J. Biol. Chem. 272, 12100-12106.
12. Gait, M.J., and Karn, J. (1993). RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem. Sci. 18, 255-259.
13. Garcia-Martinez, L., Ivanov, D., and Gaynor, R. (1997). Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem. 272, 6951-6958.
14. Ghosh, S., Selby, M., and Peterlin, B. (1993). Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. J. Mol. Biol. 234, 610-619.
15. Hart, C., Galphin, J., Westhafer, M., and Schochetman, G. (1993). TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J. Virol. 67, 5020-5024.
16. Herrmann, C., and Rice, A. (1993). Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virol. 197, 601-608.
17. Herrmann, C., and Rice, A. (1995). LentivirusTat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69, 1612-1620.
18. Jones, K.A. (1997). Taking a new TAK on Tat transactivation. Genes Dev. 11, 2593-2599.
19. Jones, K.A., and Peterlin, B.M. (1994). Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63, 717-743.
20. Keen, N., Gait, M., and Karn, J. (1996). Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA 93, 2505-2510.
21. Keen, N., Churcher, M., and Karn, J. (1997). Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16, 5260-5272.
22. Lee, J., and Greenleaf, A. (1997). Modulation of RNA polymerase II elongation efficiency by C-terminal heptapeptide repeat domain kinase I. J. Biol. Chem. 272, 10990-10993.
23. Li, H., Lahti, J., and Kidd, V. (1996). Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated protein. Oncogene 13, 705-712.
24. Liao, S.-M., Zhang, J., Jeffery, D., Koleske, A., Thompson, C., Chao, D., Viljoen, M., and Vuuren, H., and Young, R. (1995). A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature 374, 193-196.
25. Luo, Y., and Peterlin, B. (1993). Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR. J. Virol. 67, 3441-3445.
26. Luo, Y., Madore, S., Parslow, T., Cullen, B., and Peterlin, B. (1993). Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J. Virol. 67, 5617-5622.
27. Madore, S., and Cullen, B. (1993). Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67, 3703-3711.
28. Maldonado, E., and Reinberg, D. (1995). News on initiation and elongation of transcription by RNA polymerase II. Curr. Opin. Cell. Biol. 7, 352-361.
29. Mancebo, H., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Blau, C., Hazuda, D., Price, D., and Flores, O. (1997). P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11, 2633-2644.
30. Marshall, N., and Price, D. (1992). Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12, 2078-2090.
31. Marshall, N., and Price, D. (1995). Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270, 12335-12338.
32. Marshall, N., Peng, J., Xie, Z., and Price, D. (1996). Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271, 27176-27183.
33. Moras, D., and Poterszman, A. (1995). Diverse modes of recognition. Curr. Biol. 5, 249-251.
34. Oubridge, C., Ito, N., Evans, P., Teo, C.-H., and Nagai, K. (1994). Crystal structure at 1.92Å resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature 372, 432-438.
35. Rechsteiner, M., and Rogers, S. (1996). PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21, 267-271.
36. Scherly, D., Boelens, W., Dathan, N., van Venrooij, W., and Mattaj, I. (1990a). Major determinants of the specificity of interaction between small nuclear ribonucleoproteins U1A and U2B″ and their cognate RNAs. Nature 345, 502-506.
37. Scherly, D., Dathan, N., Boelens, W., van Venrooij, W., and Mattaj, I. (1990b). The U2B″ RNP motif as a site of protein-protein interaction. EMBO J. 9, 3675-3681.
38. Sheline, C.T., Milocco, L.M., and Jones, K.A. (1991). Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5, 2508-2520.
39. Shilatifard, A., Conaway, J., and Conaway, R. (1997). Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II. Curr. Opin. Genet. Dev. 7, 199-204.
40. Sterner, D., Lee, J., Hardin, S., and Greenleaf, A. (1995). The yeast carboxy-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex. Mol. Cell. Biol. 15, 5716-5724.
41. Tiley, L.S., Madore, S.J., Malim, M.H., and Cullen, B.R. (1992). The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev. 6, 2077-2087.
42. Waterman, M.L., Fischer, W.H., and Jones, K.A. (1991). A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev. 5, 656-669.
43. Yang, X., Herrmann, C., and Rice, A. (1996). The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70, 4576-4584.
44. Yang, X., Gold, M.O., Tang, D.N., Lewis, D.E., Aguilar-Cordova, E., Rice, A.P., and Herrmann, C.H. (1997). TAK, an HIVTat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94, 12331-12336.
45. Zhou, Q., and Sharp, P. (1995). Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14, 321-328.
46. Zhou, Q., and Sharp, P. (1996). Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274, 605-610.
47. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M., and Price, D. (1997). Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11, 2622-2632.
48. Zwijsen, R., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. (1997). CDK-independent activation of the estrogen receptor by cyclin D1. Cell 88, 405-415.